학술논문

TO DETERMINE THE FINANCIAL IMAPCT OF INTRODUCING SC RITUXIMAB (MABTHERA) VS. CURRENTLY USED IV RITUXIMAB (MABTHERA) ON THE BUDGETS OF DIFFERENT HOSPITALS ACROSS THE KINGDOM OF SAUDI ARABIA (KSA)
Document Type
Journal
Source
VALUE IN HEALTH; OCT-NOV 2017, 20 9, pA424-pA424, 1p.
Subject
Language
English
ISSN
15244733